Principal Financial Group’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.31M | Sell |
459,038
-299
| -0.1% | -$1.51K | ﹤0.01% | 1780 |
|
|
2025
Q1 | $2.98M | Buy |
459,337
+12,024
| +3% | +$77.9K | ﹤0.01% | 1688 |
|
|
2024
Q4 | $3.28M | Buy |
447,313
+15,902
| +4% | +$117K | ﹤0.01% | 1704 |
|
|
2024
Q3 | $3.23M | Sell |
431,411
-3,215
| -0.7% | -$24.1K | ﹤0.01% | 1684 |
|
|
2024
Q2 | $3.87M | Sell |
434,626
-27,404
| -6% | -$244K | ﹤0.01% | 1616 |
|
|
2024
Q1 | $4.68M | Sell |
462,030
-45,597
| -9% | -$462K | ﹤0.01% | 1591 |
|
|
2023
Q4 | $5.11M | Sell |
507,627
-4,065
| -0.8% | -$40.9K | ﹤0.01% | 1548 |
|
|
2023
Q3 | $4.79M | Buy |
511,692
+39,762
| +8% | +$373K | ﹤0.01% | 1554 |
|
|
2023
Q2 | $11.6M | Sell |
471,930
-6,656
| -1% | -$163K | 0.01% | 1179 |
|
|
2023
Q1 | $11.1M | Sell |
478,586
-10,278
| -2% | -$239K | 0.01% | 1199 |
|
|
2022
Q4 | $12.4M | Buy |
488,864
+8,118
| +2% | +$205K | 0.01% | 1117 |
|
|
2022
Q3 | $9.27M | Buy |
480,746
+8,811
| +2% | +$170K | 0.01% | 1229 |
|
|
2022
Q2 | $12M | Buy |
471,935
+445,904
| +1,713% | +$11.4M | 0.01% | 1152 |
|
|
2022
Q1 | $670K | Buy |
26,031
+153
| +0.6% | +$3.94K | ﹤0.01% | 2058 |
|
|
2021
Q4 | $1.08M | Sell |
25,878
-12,562
| -33% | -$526K | ﹤0.01% | 1967 |
|
|
2021
Q3 | $1.67M | Sell |
38,440
-1,118
| -3% | -$48.7K | ﹤0.01% | 1902 |
|
|
2021
Q2 | $1.87M | Sell |
39,558
-540
| -1% | -$25.5K | ﹤0.01% | 1929 |
|
|
2021
Q1 | $2.06M | Buy |
40,098
+287
| +0.7% | +$14.7K | ﹤0.01% | 1848 |
|
|
2020
Q4 | $1.07M | Buy |
39,811
+8,504
| +27% | +$228K | ﹤0.01% | 1933 |
|
|
2020
Q3 | $1.08M | Sell |
31,307
-86
| -0.3% | -$2.95K | ﹤0.01% | 1857 |
|
|
2020
Q2 | $1.29M | Buy |
+31,393
| New | +$1.29M | ﹤0.01% | 1777 |
|